Overall, CLL cells can have both nuclear FoxO1 activity and ‘tonic’ Akt activity, but strong microenvironmental stimuli driving extensive Akt activation will eventually lead to FoxO1 degradation [10]. The gene discussed is FOXO1; the disease is B-cell chronic lymphocytic leukemia.